We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

205 hedge funds and large institutions have $691M invested in SANGAMO THERAPEUTICS INC in 2020 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 77 increasing their positions, 47 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 15

64% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 47

47% more call options, than puts

Call options by funds: $15.5M | Put options by funds: $10.5M

45% more capital invested

Capital invested by funds: $476M → $691M (+$215M)

8% more funds holding

Funds holding: 190 → 205 (+15)

9.43% less ownership

Funds ownership: 64.16% → 54.73% (-9.4%)

Holders
205
Holders Change
+15
Holders Change %
+7.89%
% of All Funds
4.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
77
Reduced
47
Closed
15
Calls
$15.5M
Puts
$10.5M
Net Calls
+$4.97M
Net Calls Change
+$3.77M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$15.2M
2
Two Sigma Investments
Two Sigma Investments
New York
+$10.9M
3
BlackRock
BlackRock
New York
+$8.98M
4
GPP
Great Point Partners
Connecticut
+$8.78M
5
GLA
Great Lakes Advisors
Illinois
+$7.81M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$14.7M
2
Citadel Advisors
Citadel Advisors
Florida
-$10.6M
3
Millennium Management
Millennium Management
New York
-$9.48M
4
Marshall Wace
Marshall Wace
United Kingdom
-$8.68M
5
TCM
Tang Capital Management
California
-$4.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
OSAM
201
O'Shaughnessy Asset Management
Connecticut
$1K +$538 +58 New
ECM
202
Estabrook Capital Management
New York
$125 – – –
TI
203
tru Independence
Oregon
$9 – – –
EC
204
EcoR1 Capital
California
– -$14.7M -2,308,079 Closed
Millennium Management
205
Millennium Management
New York
– -$9.48M -1,488,020 Closed
Marshall Wace
206
Marshall Wace
United Kingdom
– -$8.68M -1,363,039 Closed
3C
207
361 Capital
Colorado
– -$695K -109,161 Closed
Balyasny Asset Management
208
Balyasny Asset Management
Illinois
– -$592K -92,994 Closed
Squarepoint
209
Squarepoint
New York
– -$339K -53,294 Closed
MWM
210
Merriman Wealth Management
Washington
– -$166K -26,000 Closed
Capital Fund Management (CFM)
211
Capital Fund Management (CFM)
France
– -$164K -25,822 Closed
CM
212
Caption Management
Oklahoma
– -$232K -25,000 Closed
MAM
213
Martingale Asset Management
Massachusetts
– -$122K -19,050 Closed
BFM
214
Boothbay Fund Management
New York
– -$71K -11,100 Closed
ASN
215
Advisory Services Network
Georgia
– -$1K -200 Closed
5 6 7 8
9

SGMO Hedge Fund Activity: Q2 2020 in Review

205 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2020, worth a combined $691M — up 45% from $476M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new SGMO positions and 15 closed out — a net gain of 16 holders — while 77 added to existing stakes and 47 trimmed.

The largest buyer was State Street, adding an estimated $15.2M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $14.7M sold.

  • 205 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2020, up from 190 in Q1 2020.
  • Funds reported $691M of SANGAMO THERAPEUTICS INC stock for Q2 2020, up 45% quarter-over-quarter.
  • 31 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2020 and 15 closed out, a net change of +16 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2020 was State Street, an estimated $15.2M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2020 was EcoR1 Capital, an estimated $14.7M sold.

Based on aggregated 13F filings for Q2 2020.